Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma
- 31 August 2009
- Vol. 146 (2), 232-240
- https://doi.org/10.1016/j.surg.2009.03.036
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cellsInternational Journal of Cancer, 2009
- Osteopontin Promotes Vascular Endothelial Growth Factor–Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine MechanismsCancer Research, 2008
- Osteopontin‐c is a selective marker of breast cancerInternational Journal of Cancer, 2007
- An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinomaOncogene, 2007
- Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferationSurgery, 2006
- Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: Novel post-transcriptional, post-translational regulationClinical & Experimental Metastasis, 2005
- Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathwaysOncogene, 2003
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJournal of Clinical Investigation, 2001
- Antibodies to different peptides in osteopontin reveal complexities in the various secreted formsJournal of Cellular Biochemistry, 2000
- Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffeeInternational Journal of Cancer, 1990